Deciphera Pharmaceuticals, Inc. Accrued Professional Fees, Current
Deciphera Pharmaceuticals, Inc. had Accrued Professional Fees, Current of $6.01 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2024-05-10
- 2024-03-31: Accrued Professional Fees, Current $6.01M.
- 2023-12-31: Accrued Professional Fees, Current $5.67M.
- 2023-09-30: Accrued Professional Fees, Current $5.01M.
- 2023-06-30: Accrued Professional Fees, Current $4.02M.
| Period end | Accrued Professional Fees, Current |
|---|---|
| 2024-03-31 | $6.01M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $5.67M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $5.01M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $4.02M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $4.49M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $4.28M 10-K · filed 2024-02-07 |
| 2022-09-30 | $3.76M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.84M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.15M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $5.63M 10-K · filed 2023-02-07 |
| 2021-09-30 | $6.12M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $5.43M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $4.52M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $3.31M 10-K · filed 2022-02-08 |
| 2020-09-30 | $2.51M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.38M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $3.15M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $3.81M 10-K · filed 2021-02-09 |
| 2019-09-30 | $2.42M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $1.64M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $1.47M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $747.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $644.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $582.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $652.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $353.00K 10-K · filed 2019-03-14 |
| 2016-12-31 | $240.00K 10-K · filed 2018-03-28 |